What does Intersouth Partners invest in?
Intersouth Partners invests most often at Series A and Series B (54% of the rounds on record), in sectors such as Life Science and Technology.

United States · Investor
Last cheque observed Sep 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietVC firm
Follow Intersouth Partners and see its new cheques in your feed.Start following
127 rounds on record
Mostly Series A and Series B: 54% of its rounds
Sole investor in 8 rounds, median $1.9M
17 exits from the portfolio
Intersouth Partners invested in more than 100 early-stage life science and technology companies across the Southeast.From their own website
Every round we can evidence, newest first127 appearances
1 round
3 rounds
2 rounds
7 rounds
9 rounds
9 rounds
10 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Companies it backed that were later bought or listed17 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as Intersouth Partners. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Intersouth Partners put money into.
Episodes that name Intersouth Partners in their description, not their title.

Top Healthcare Investor: HealthQuest’s Garheng Kong
WithGarheng Kong
MentionsDuke UniversityHealthQuest CapitalIntersouth Partners+1
Intersouth Partners invests most often at Series A and Series B (54% of the rounds on record), in sectors such as Life Science and Technology.
127 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2018.
Its most recent investments on record: Lyra Therapeutics (Series B, Sept 2018).
The median round it joins is $30M.
Rarely, if at all: none of its 127 investments on record names it as the lead.
Most of the companies it backs are in the United States (100%).
No investments in the last 12 months; the latest was in Sept 2018.
Most often Polaris Partners (21 rounds together), Noro-Moseley Partners (8 rounds together) and Skyline Ventures (8 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it